Abstract
Letters and Corrections1 March 1988Pneumocystis PneumoniaERIC P. NEIBART, M.D.ERIC P. NEIBART, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-108-3-489_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Conte and associates (1) report their results with reduced-dose intravenous pentamidine and inhaled pentamidine as therapy forPneumocystis cariniipneumonia in patients with the acquired immunodeficiency syndrome. Several questions, however, are raised by their presentation. Clinical and objective criteria for failure, and progression of success are not clearly defined. The authors state four patients had repeat bronchoscopy and persistent organisms were seen. Were these the patients that had relapses? The authors state that 90% of evaluable patients had a satisfactory response to inhaled pentamidine. This statement appears to be questionable if three patients had progression of disease...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
